Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”


HHS - 769 - Advisory Committee on Infant and Maternal Mortality - Authorized by Law
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameAdvisory Committee on Infant and Maternal MortalityAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number769
Original Establishment Date6/28/1991Committee StatusChartered
Actual Termination Date Committee URLhttps://www.hrsa.gov/advisory-committees/Infant...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*38
Current Charter Date9/30/2021Designated Fed Officer Position Title*Public Health Analyst/DFO
Date Of Renewal Charter9/30/2023Designated Federal Officer PrefixMs.
Projected Termination Date Designated Federal Officer First Name*Vanessa
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Lee
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixMPH
Specific Establishment Authority*42 U.S.C. 217aDesignated Federal Officer Phone*(301) 443-9992
Effective Date Of Authority*11/17/1962Designated Federal Officer Fax*(301) 594-0878
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*vlee1@hrsa.gov
Committee Type*Continuing
Presidential*No
Committee Function*National Policy Issue Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Committee met four times in Fiscal Year (FY) 2022. Three meetings were held virtually via webinar and one meeting was held in-person and virtually on Tribal land. The Committee is comprised of both voting (public) members and non-voting ex-officio members.
How is membership balanced?*The 21 public members of the Committee, including the Committee Chair, are selected by the Secretary, and a Committee Chair is selected among the members by the HRSA Administrator. Members shall be representatives of both the public and private sectors. Members from the private sector may represent corporations and foundations, the religious community, consumers, health and other professional organizations, health plans, and employers. Members from the public sector may include elected officials and health and human services administrators from the state and local levels including representatives of minority, rural, and urban interests. The Committee also has ex-officio members that include: the Assistant Secretary for Health or designee; the Director of HHS Office on Women’s Health or designee; the Deputy Assistant Secretary for Minority Health/Director of the Office of Minority Health or designee; the HRSA Administrator or designee; a representative from the Agency for Healthcare Research and Quality; the Director of the Centers for Disease Control and Prevention’s (CDC) Center on Birth Defects and Developmental Disabilities or designee; the Director of CDC’s Division of Reproductive Health or designee; a representative from the CDC’s National Center for Health Statistics; the Administrator for the Centers for Medicare & Medicaid Services or designee; the Assistant Secretary for Children and Families or designee; a representative from the National Institutes of Health’s National Institute of Child Health and Human Development (NICHD); a representative from the Indian Health Service; a representative from the Substance Abuse and Mental Health Services Administration (SAMHSA); the Assistant Secretary for Food and Consumer Services, the United States Department of Agriculture or designee; a representative from the Department of Education; a representative from the Department of Housing and Urban Development; a representative from the Department of Labor; and any appropriately qualified representative of the Department of HHS or other agencies of the federal government designated by the Secretary as ex-officio members. The membership balance of the committee is not static and may change, depending on the work of the committee.
How frequent & relevant are cmte mtgs?*Meetings are typically held four times per FY. Committee meetings are necessary to review current evidence and data, and to generate new ideas and recommendations in order to maintain progress on reducing infant and maternal deaths and disparities in infant/maternal mortality. This is addressed through the activities and efforts of a number of workgroups (that are formed on an ad hoc basis), and the discussion of new policies and scientific findings pertaining to maternal and infant health. In addition, the Committee continues to monitor and review the Healthy Start program and its evaluation, as well as Healthy People 2030 objectives.

ACIMM advises the Secretary of the Department of Health and Human Services (HHS) on department activities, partnerships, policies, and programs directed at reducing infant mortality, maternal mortality and severe maternal morbidity, and improving the health status of infants and women before, during, and after pregnancy. The Committee provides advice on how best to coordinate federal, state, local, tribal, and territorial governmental efforts designed to improve infant mortality, related adverse birth outcomes, and maternal health, as well as influence similar efforts in the private and voluntary sectors. The Committee provides guidance and recommendations on the policies, programs, and resources required to address the disparities and inequities in infant mortality, related adverse birth outcomes and maternal health outcomes, including maternal mortality and severe maternal morbidity. With its focus on underlying causes of the disparities and inequities seen in birth outcomes for women and infants, the Committee advises the Secretary on the health, social, economic, and environmental factors contributing to the inequities and proposes structural, policy, and/or systems level changes.
Why advice can't be obtained elsewhere?*This Committee is necessary to provide the HHS with ongoing counsel and advice from a broad range of public and private sector expertise not available within HHS. The work of the Committee is especially important in light of the continued rise in preterm births, a major contributor to infant mortality, and an increased focus and attention on maternal health, maternal mortality, and severe maternal morbidity. In addition disparities in infant and maternal outcomes are persistent and must be addressed.
Why close or partially close meetings?N/A - ACIMM meetings are open to the public.
Recommendation RemarksNo reports or new recommendations were issued in FY2022.
While two Committee letters from June 2020 were mentioned in a prior ACR, the recommendations stemming from the June 2020 letters were erroneously omitted and never calculated into the ACIMM’s total recommendations for FY 2020 and FY 2021. As a result, the recommendation total is updated to include the recommendations contained in those two letters.

The Committee's Executive Secretary continues to be the HRSA Associate Administrator for MCHB.

The following members received a one-time 6 month extension on ACIMM and as a result have new term end dates of 12/15/2022: Edward Ehlinger (prior term end date of 6/15/2022); Colleen Malloy (prior term end date of 7/25/2022); Janelle Palacios (prior term end date of 7/6/2022); Magda Peck (prior term end date of 7/6/2022); and Belinda Pettiford (prior term end date of 6/15/2022).
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentNoAction Reallocate ResourcesYes
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchNoAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentNA
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentNAGrants Review CommentNA
Number Of Recommendations*92Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentNo new recommendations made in FY2022. However, in June of 2020, twelve recommendations had been developed by the Committee to address the effects of the COVID-19 pandemic on prenatal, labor and delivery, and newborn care, for the purpose of preventing increases in maternal and infant mortality and morbidity. These recommendations have been added to the total number of recommendations made by the Committee, which has gone from 80 to 92. The COVID-19 recommendations can be found on the ACIMM website: https://www.hrsa.gov/sites/default/files/hrsa/advisory-committees/infant-mortality/correspondence/june-29-covid-19-recommendations.pdf

The Committee has been instrumental in providing guidance for the strengthening of programs and policies aimed at reducing infant and/or maternal mortality, as the COVID-19 pandemic continues and health disparities persist or worsen. The Committee also advises the Secretary and HRSA on issues around gaps in services, HHS programs, and research focused on preterm birth, infant mortality, maternal mortality, and health disparities/health equity.

The last set of recommendations were made in August 2021 and were focused specifically on maternity and infant care systems and financing; workforce expansion and diversification; environmental risks; border health; and data and research for action.
Access Agency WebsiteYes
% of Recs Fully Implemented*16.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThe Committee last submitted recommendations in August of 2021. They were reviewed by the Department, and continue to be used as agencies think about national efforts and activities across the Department to improve birth outcomes. A review of the Committee's recommendations made prior to 2021 was done in FY22 and several had been found to be fully implemented by HHS agencies, which accounts for the increase in percent of recs fully implemented. For example, HRSA has partnered with professionals to develop clinical guidelines for well-woman visits (i.e., the Women's Preventive Services Initiative); HRSA has also increased efforts to ensure mental/behavioral health and social support services for women (e.g., National Maternal Mental Health Hotline); and HRSA strengthened state leadership and capacity to improve birth outcomes and reduce infant mortality through the Collaborative Improvement and Innovation Network (CoIIN) from 2012 to 2017.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*68.00%Access PublicationsNo
% of Recs Partially Implemented CommentThe Committee last submitted recommendations in August of 2021. They were reviewed by the Department and continue to be used as agencies think about national efforts and activities across the Department to improve birth outcomes. Many recommendations presented by the committee have been partially implemented by an agency directly or in coordination with other agencies. For example, in July 2022 CMS released its Maternity Care Action Plan, which included postpartum coverage extensions through Medicaid.Access OtherNo
Agency Feedback*YesAccess Comment
Agency Feedback Comment*The Committee last submitted recommendations in August of 2021. They were reviewed by the Department, and a letter from the Secretary was sent to the Committee in January 2022 acknowledging receipt and describing some of the recommendations that had been implemented. The HHS letter to the Committee with feedback on their recommendations is publicly shared on the Committee website: https://www.hrsa.gov/advisory-committees/infant-mortality/correspondence.html

The Committee Chair, HRSA Administrator, Executive Secretary of the Committee, and the Director of the Division that administers the Healthy Start program (or their designees) provided updates at committee meetings, specifically addressing progress on recommendations or questions raised. Additional feedback from various HHS agencies was provided to the Committee at the FY2022 Committee meetings. In addition, speakers from relevant HHS agencies and programs were invited to present on emerging issues and strategies to keep Committee members apprised of changes or advances (many of these federal partners also serve as ex-officios of the Committee). In addition, feedback is provided by other agencies and organizations (including outside of HHS) as appropriate.
Narrative Description*ACIMM recommends that all investment and policy decisions, at all levels and sectors of government, be made with special consideration of their impact on infants, mothers, and women throughout their life course.

ACIMM recommends an immediate policy and investment focus on all mothers and infants in our nation, with increased investment and support to prevent pregnancy complications, adverse birth outcomes, and suboptimal health over their life-course, especially for mothers and infants who are members of Black, Indigenous, and People of Color (BIPOC) communities, and those who face additional challenges because of disability; wealth inequities; inadequate insurance coverage; insecure housing, homelessness, or residential segregation; or being undocumented, immigrants, or incarcerated.

ACIMM developed a set of recommendations focused specifically on maternity and infant care systems and financing, workforce expansion and diversification, environmental risks, and border health, and manifest the necessity to address racial and social inequities. These recommendations offer a pathway to advance birth equity and assure the conditions for optimal birth for all people. ACIMM also recommends increased investment and support for data systems and focused research and evaluation to monitor and assess the impact of these recommendations on maternal and infant mortality and severe maternal morbidity.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$36,000.00Est Payments to Non-Fed Members Next FY*$18,750.00
Payments to Federal Members*$27,328.00Est. Payments to Fed Members Next FY*$50,752.00
Payments to Federal Staff*$294,860.00Estimated Payments to Federal Staff*$309,826.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$10,596.00Est Travel Reimb Non-Fed Members nextFY*$28,148.00
Travel Reimb. For Federal Members*$3,278.00Est Travel Reimb For Fed Members*$2,387.00
Travel Reimb. For Federal Staff*$3,793.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$132,857.00Est. Other Costs Next FY*$175,000.00
Total Costs$508,712.00Est. Total Next FY*$584,863.00
Date Cost Last Modified11/15/2022 4:32 PMEst. Fed Staff Support Next FY*1.70
Federal Staff Support (FTE)*1.70Est Cost RemarksOther costs include the HRSA meeting BPA logistics contract. Projecting two virtual and one in-person meeting in FY 2023.
Cost RemarksOther costs include the HRSA meeting BPA logistics contract.  
Hide Section - Interest Areas

Interest Areas

Category
Area
Basic Science
Basic Sciences
Business
Small Business
Civil Rights
Children
Civil Rights
Disabled
Equal Opportunity
Minorities
Native Americans
Women
Computer Technology
Information Technology
Data
Data Quality
Education
Education
Training
Eligibility
Eligibility Programs
Social Services
Welfare
Environment
Environmental Issues
Federal Employment
Public Services
Food and Drugs
Food and Drugs
Government
Federal Government
State Government
Tribal Government
Health
Health Care
Hospitals
Medical Education
Medical Practitioners
Nutrition
Nutrition for Women, Infants and Children
Physical Fitness
Public Health
Safety
Treatment
Housing and Urban
Housing and Urban Development
Justice
Drug Abuse Policy and Enforcement
Justice
Juvenile Justice
Prevention
Research and Statistics
Labor
Employment
Job Training
Wages
Workforce and Occupations
Medicine
Diseases
Health and Health Research
Illnesses
Medicine and Dentistry
Research
Research and Statistics
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-040460Advisory Committee on Infant and Maternal Mortality2021
 COM-038735Advisory Committee on Infant Mortality2020
 COM-036618Advisory Committee on Infant Mortality2019
 COM-034831Advisory Committee on Infant Mortality2018
 COM-001757Advisory Committee on Infant Mortality2017
 COM-002290Advisory Committee on Infant Mortality2016
 COM-004113Advisory Committee on Infant Mortality2015
 COM-004519Advisory Committee on Infant Mortality2014
 COM-005853Advisory Committee on Infant Mortality2013
 COM-006581Advisory Committee on Infant Mortality2012
 COM-008028Advisory Committee on Infant Mortality2011
 COM-008846Advisory Committee on Infant Mortality2010
 COM-010409Advisory Committee on Infant Mortality2009
 COM-010736Advisory Committee on Infant Mortality2008
 COM-012125Advisory Committee on Infant Mortality2007
 COM-012873Advisory Committee on Infant Mortality2006
 COM-014035Advisory Committee on Infant Mortality2005
 COM-014801Advisory Committee on Infant Mortality2004
 COM-015954Advisory Committee on Infant Mortality2003
 COM-016763Advisory Committee on Infant Mortality2002
 COM-017608Advisory Committee on Infant Mortality2001
 COM-018371Advisory Committee on Infant Mortality2000
 COM-019590Advisory Committee on Infant Mortality1999
 COM-020652Advisory Committee on Infant Mortality1998
 COM-021667Advisory Committee on Infant Mortality1997